- Home
- CLLS vs CGC Comparison
CLLS vs CGC Comparison
Compare CLLS & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | CGC |
|---|---|---|
| Founded | 1999 | N/A |
| Country | France | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.3M | 404.3M |
| IPO Year | 2014 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CLLS | CGC |
|---|---|---|
| Price | $3.24 | $0.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | 48.3K | ★ 7.1M |
| Earning Date | 03-19-2026 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.75 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | N/A | $8.04 |
| Revenue Next Year | N/A | $4.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | $0.77 |
| 52 Week High | $5.48 | $2.38 |
Technical Indicators
Market Signals| Indicator | CLLS | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 39.22 |
| Support Level | $3.32 | N/A |
| Resistance Level | $3.83 | $1.25 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 22.37 | 41.23 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.